Gotham Asset Management, LLC

Position in BMRN — Biomarin Pharmaceutical Inc

CIK 1510387 NEW YORK, NY

Position in BMRN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,638,838

-$8,195,562 QoQ

Shares Held

28,641

-83.5% QoQ

Ownership

0.015%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#235

of 564 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Gotham Asset Management, LLC holds $433,918,027 across 48 Biotechnology names. BMRN ranks #20 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	719,545	$81,567,621
2	REGN	Regeneron Pharmaceuticals, Inc.	105,165	$65,574,584
3	HALO	Halozyme Therapeutics, Inc.	739,273	$57,862,897
4	EXEL	Exelixis, Inc.	892,663	$48,569,793
5	ROIV	Roivant Sciences Ltd.	1,349,465	$47,757,566
6	JAZZ	Jazz Pharmaceuticals plc	112,014	$26,992,013
7	RVMD	Revolution Medicines, Inc.	120,702	$22,605,070
8	ALNY	Alnylam Pharmaceuticals, Inc.	42,051	$12,658,612

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,638,838	28,641	-83.5%	Shares	Sole	2026-08-14
2026-03-31	$9,834,400	174,091	-35.4%	Shares	Sole	2026-05-15
2025-12-31	$16,017,038	269,511	+1.6%	Shares	Sole	2026-02-17
2025-09-30	$14,370,381	265,332	+122.1%	Shares	Sole	2025-11-14
2025-06-30	$6,565,946	119,446	+151.6%	Shares	Sole	2025-08-14
2025-03-31	$3,355,583	47,469	+304.5%	Shares	Sole	2025-05-15
2024-12-31	$771,275	11,734	-49.8%	Shares	Sole	2025-02-14
2024-09-30	$1,644,434	23,395	+856.5%	Shares	Sole	2024-11-14
2023-12-31	$235,843	2,446	-39.7%	Shares	Sole	2024-02-14
2023-09-30	$358,874	4,056	+7.9%	Shares	Sole	2023-11-14
2023-03-31	$365,427	3,758	+16.0%	Shares	Sole	2023-05-15
2021-09-30	$250,496	3,241	-44.5%	Shares	Sole	2021-11-15
2020-06-30	$720,552	5,842	-47.0%	Shares	Sole	2020-08-13
2020-03-31	$931,190	11,020	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.